Axon Enterprise, Inc $AXON Stock Acquired by Calamos Wealth Management LLC

Calamos Wealth Management LLC grew its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 1,150.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,009 shares of the biotechnology company’s stock after buying an additional 12,889 shares during the quarter. Calamos Wealth Management LLC’s holdings in Axon Enterprise were worth $5,919,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. State Street Corp raised its position in Axon Enterprise by 5,700.2% during the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock valued at $119,724,905,000 after purchasing an additional 209,879,882 shares during the period. Envestnet Asset Management Inc. lifted its stake in shares of Axon Enterprise by 18,050.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after purchasing an additional 13,127,348 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of Axon Enterprise by 4.3% in the 2nd quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock worth $4,672,432,000 after purchasing an additional 345,365 shares during the period. Robeco Institutional Asset Management B.V. boosted its holdings in shares of Axon Enterprise by 391,214.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock worth $2,952,943,000 after purchasing an additional 6,987,098 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of Axon Enterprise by 8,432.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock worth $1,983,414,000 after purchasing an additional 3,496,493 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

AXON has been the topic of several recent research reports. Northcoast Research increased their price target on Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a report on Tuesday, August 11th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Tuesday. Piper Sandler reiterated an “overweight” rating and set a $540.00 price objective (down from $561.00) on shares of Axon Enterprise in a research report on Friday. Royal Bank Of Canada lowered their target price on shares of Axon Enterprise from $735.00 to $615.00 and set an “outperform” rating for the company in a report on Friday. Finally, Northland Securities set a $540.00 price target on shares of Axon Enterprise in a report on Friday. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $631.35.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q3 revenue reached a record $909 million, up 28% year over year, while software and services revenue rose 43%. Axon also reported AI annual recurring revenue above $100 million, signaling continued demand for its software and AI offerings. Axon Q3 results
• Neutral Sentiment: Axon committed an additional $1.2 billion to drone maker Skydio, bringing its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The move could expand Axon’s Drone as First Responder business, but its scale also raises investment and execution risks. Reuters: Axon invests in Skydio
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of $908.55 million fell short of analyst expectations. Axon’s 2026 revenue forecast was reduced to $3.6 billion from a consensus of about $3.7 billion; its Q4 revenue guidance also came in below estimates. The company cited delays in federal counter-drone projects, while margin pressure added to concerns. Zacks: Q3 miss and outlook
• Negative Sentiment: Several analysts lowered price targets after the results, and Craig Hallum downgraded AXON from Buy to Hold, adding to pressure on investor sentiment. Benzinga: analyst forecast changes
• Negative Sentiment: A class-action lawsuit over Axon’s license-plate surveillance practices is a potential additional legal and reputational overhang. Class-action announcement

Insider Activity at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the completion of the sale, the chief executive officer owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the sale, the insider directly owned 97,761 shares of the company’s stock, valued at approximately $61,266,818.70. This trade represents a 8.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 37,397 shares of company stock valued at $21,234,034. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Trading Down 18.2%

Shares of AXON stock traded down $69.56 on Friday, reaching $313.00. 5,224,684 shares of the company’s stock were exchanged, compared to its average volume of 975,165. The company’s fifty day simple moving average is $441.53 and its 200 day simple moving average is $475.20. Axon Enterprise, Inc has a 52 week low of $307.00 and a 52 week high of $665.07. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $25.43 billion, a PE ratio of 100.32, a P/E/G ratio of 8.09 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The business had revenue of $908.55 million during the quarter, compared to analysts’ expectations of $934.33 million. During the same quarter in the previous year, the business earned $1.17 EPS. The business’s revenue for the quarter was up 27.8% on a year-over-year basis. As a group, analysts forecast that Axon Enterprise, Inc will post 2.10 EPS for the current year.

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals.

The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Founded in 1993 as TASER International, the company adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into connected devices and software.